## **Core Concept**
Carisoprodol is a prodrug that is metabolized in the liver to its active metabolite. It acts as a centrally acting muscle relaxant. The primary mechanism of action involves modulation of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA).

## **Why the Correct Answer is Right**
The correct metabolite of carisoprodol is **meprobamate**, which is an anxiolytic drug that belongs to the carbamate class. Meprobamate is known to enhance the activity of GABA, similar to its parent compound, thereby producing muscle relaxation and anxiolytic effects. Carisoprodol is converted to meprobamate by cytochrome P450 enzymes in the liver.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is incorrect because it is not identified as a metabolite of carisoprodol.
- **Option B:** is incorrect as there is no well-known association with carisoprodol metabolism.
- **Option D:** is incorrect because it does not correspond to a recognized metabolite of carisoprodol.

## **Clinical Pearl / High-Yield Fact**
A significant clinical pearl is that carisoprodol, due to its conversion to meprobamate, shares a similar potential for abuse with meprobamate and other carbamates. This is crucial for clinicians when prescribing muscle relaxants, especially in patients with a history of substance abuse.

## **Correct Answer:** . Meprobamate